Navigation Links
GeneNews Announces Second Quarter Results
Date:8/7/2008

p>Expenses

Research and

development 3,044,225 1,772,371 5,229,981 4,361,474

General and

administrative 806,675 643,191 1,319,236 1,315,266

Stock

compensation 352,264 131,747 494,538 278,186

Amortization of

intellectual

property 110,537 110,537 221,074 221,074

Interest on long

term debt 28,172 1,538 58,700 4,191

-------------------------------------------------------------------------

4,341,872 2,659,384 7,323,528 6,180,191

Interest income 58,634 357,865 159,694 541,186

-------------------------------------------------------------------------

Net and

comprehensive

loss for the

period $ (3,994,800) $ (2,301,519) $ (6,581,110) $ (3,972,769)

Deficit, beginning

of period (35,934,440) (25,385,336) (33,348,130) (23,714,086)

-------------------------------------------------------------------------

Deficit, end

of period $(39,929,240) $(27,686,855) $(39,929,240) $(27,686,855)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Net and

comprehensive

loss per common

share

Basic and fully

diluted $ (0.07) $ (0.04) $ (0.12) $ (0.07)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Weighted average

number of common

shares outstanding

Basic and fully

diluted 55,623,367 55,441,019 55,571,069 55,441,019

-----------------------------------------------
'/>"/>

SOURCE GeneNews Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
4. GeneNews receives ISO 13485 accreditation
5. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
6. GeneNews announces 2007 year end results
7. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
8. GeneNews Announces First Quarter Results
9. Genenews adds two members to its Board of Directors
10. GeneNews announces management changes to support commercialization of ColonSentry(TM)
11. GeneNews launches worlds first blood test for colorectal cancer screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Mathematic studies at the ... , and funded by the Jeffrey Epstein VI Foundation ... can be visually identified for elimination. These aggressive cells are ... which shows a topological map of what to look for ... research, for while tumor cells can be extracted from biopsy, ...
(Date:8/21/2014)... Chester, NJ (PRWEB) August 21, 2014 ... of personal selling optimization technology and services for ... publication of “Grading Pharma’s Use of New Commercial ... of Measurement & Analytics. , The article examines ... marketing yield that are being tested in the ...
(Date:8/21/2014)... of last week RENU 28, the world's first and only ... purchase in Australia and New Zealand, and the response has ... if you think about the definition of aging, it's really ... your body. If you think about the definition of anti-aging, ... RENU 28 does is it works with these tiny little ...
(Date:8/20/2014)... For the first time, chemists have succeeded in measuring ... time resolution. The study reveals how vibration of a ... groups. , The study was performed at the ... from the University of Jyvskyl works as a visiting ... in the study. The second team was lead by ...
Breaking Biology Technology:Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2RENU 28 Skin Care Now Available in Australia and New Zealand 2Seeing a molecule breathe 2
... program draws on diverse group to advise on complex infertility ... ... Science,Center of the Bay Area (RSC) is launching an innovative advisory group,designed ... rare development in private medical groups in the,United States. RSC,s ethics ...
... ISELIN, N.J., Nov. 7 SyntheMed, Inc. (OTC,Bulletin ... development,and commercialization of anti-adhesion, tissue repair and drug ... universal shelf registration,statement with the Securities and Exchange ... will allow SyntheMed to sell, from time to,time, ...
... Nov. 7 Transgenomic Inc. (OTC,Bulletin Board: TBIO) announces the following Webcast: ... Conference Call, ... Where: http://www.transgenomic.com/events.asp?id=6 , How: ... at the ...
Cached Biology Technology:California IVF Experts Tap Ethics Committee for Guidance 2SyntheMed Files Universal Shelf Registration 2Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast 2
(Date:8/20/2014)... persist in a cold, dark world. A UT microbiology ... waters and sediments from a shallow lake deep beneath ... supports microbial ecosystems. , The National Science Foundation-funded ... for life in other extreme environments, both on Earth ... in the current edition of the science journal ...
(Date:8/20/2014)... this image of the Para and Mato Grosso states ... intentionally set in order to deforest the land. Deforestation ... trees where the land is thereafter converted to a ... to farms, ranches, or urban use. The herringbone-patterned tan ... Rainforest in the middle of the image are evidence ...
(Date:8/20/2014)... Institutes of Health has awarded the Oklahoma Medical Research ... research on anthrax and the bacteria,s effects on humans. ... Ph.D., and his colleagues have studied the human immune ... Centers for Human Immunology. The original funding came soon ... the heels of the terrorist attacks of Sept. 11, ...
Breaking Biology News(10 mins):University of Tennessee research uncovers subglacial life beneath Antarctic ice sheet 2$14.5 million grant awarded to continue anthrax studies 2
... Singapore, September 3, 2010 Novartis announced today ... (NITD), in collaboration with researchers from the Genomics Institute ... and Public Health Institute and The Scripps Research Institute ... a next generation treatment for drug resistant malaria. Major ...
... the extreme Texas summer heat? Try being an ovulating ... dairy cows suffer from damage to their ovarian follicles. ... also be damaged, said Dr. Todd Bilby, Texas AgriLife ... other studies have shown the eggs she ovulates for ...
... pharmaceutical breakthroughs require 21st-century drug discovery tools, such ... high-throughput screening of effective, new compounds. That,s the ... be held Sept. 11 on "Twenty-first Century Bioscience: ... feature a variety of cutting-edge advances in the ...
Cached Biology News:Novartis and collaborators discover novel antimalarial drug candidate 2Novartis and collaborators discover novel antimalarial drug candidate 3Test-tube calf embryos more likely to survive Texas summers 2Test-tube calf embryos more likely to survive Texas summers 3University at Buffalo symposium on in silico methods, high throughput screening 2University at Buffalo symposium on in silico methods, high throughput screening 3
Syd-2 (cL-19)...
... for isolation and affinity purification of ... peptides. Hydrophobic, monodisperse magnetic particles (2.8 ... groups, further surface activation is not ... with optimal orientation for affinity purification ...
ZO-2 (H-110)...
p-Bcl-2 (Thr 74)...
Biology Products: